DEMAREE JOHN 4
4 · G1 Therapeutics, Inc. · Filed Jan 2, 2019
Insider Transaction Report
Form 4
DEMAREE JOHN
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to Buy)
2019-01-02+60,000→ 60,000 totalExercise: $19.56Exp: 2029-01-02→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% of the shares on January 02, 2020, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.